Posted by Michael Wonder on 16 Nov 2015
Pembrolizumab has an additional benefit in certain patients with advanced melanoma says IQWiG
16 November 2015 - In treatment experienced patients in whom the use of ipilimumab as the next treatment is suitable, there is an indication of a considerable added value.
For more details, go to: https://www.iqwig.de/de/presse/pressemitteilungen/pressemitteilungen/pembrolizumab-bei-fortgeschrittenem-melanom-zusatznutzen-bei-bestimmten-patienten.7057.html
